L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Investigational calcium channel blockers for the treatment of hypertension
Juan Tamargo,Luis M. Ruilope +1 more
TL;DR: Dual L/N- and L/T-type CCBs may exhibit therapeutic advantages over L-type blockers in hypertensive patients with chronic kidney disease, but further large-scale, long-term comparative trials are needed to confirm that these differences translate into improved clinical outcomes.
Journal ArticleDOI
Antihypertensive Treatment Efficacy in Type II Diabetes Mellitus Dissociation Between Casual and 24-Hour Ambulatory Blood Pressure
TL;DR: In this article, the efficacy of a first-line antihypertensive drug when assessed by casual and ambulatory blood pressure determinations in patients with type II diabetes mellitus in whom 24-hour ambulatory monitoring confirms or fails to confirm the diagnosis of hypertension was examined.
Journal ArticleDOI
Microalbuminuria as an intermediate endpoint in essential hypertension: evidence is coming.
Josep Redon,Luis M. Ruilope +1 more
TL;DR: Large randomized, controlled trials and their metaanalyses provide the strongest evidence about several aspects of antihypertensive therapy, including left ventricular hypertrophy, intima–media thickness, renal function and new onset diabetes.
Journal Article
Role of the control of phosphate in the progression of chronic renal failure.
TL;DR: Despite the maintenance of normal levels of serum phosphate in group I, serum creatinine increased in the same proportion as in group II, and a paired t test did not show any difference between the progression of the renal failure before or after the control of serum phosphorus.
Journal ArticleDOI
New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial
Cristina Sierra,Luis M. Ruilope +1 more
TL;DR: Diuretics and -blockers and their association are not associated with a lower prevalence of new-onset diabetes, on the contrary, calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotENSin receptor blockers, alone or in association with diuretics, are associated with an lower prevalence.